WHNP-BC study materials
WHNP-BC study resources

WHNP-BC common mistakes

WHNP-BC · Understand the traps and how to avoid them.

Mistake 1

On 'next best step' items, orders a confirmatory test (beta-hCG, ultrasound, CBC) when the stem already contains red-flag findings that require immediate action - e.g., a hemodynamically unstable patient with a positive pregnancy test and free fluid, or a woman with heavy bleeding and orthostatic vitals.

NP training and day-to-day practice are diagnostically oriented, so the reflex is to 'get the answer' before acting. Exam items deliberately reward triage of stability and can't-miss conditions ahead of diagnostic elegance.

What to do instead

Read every stem twice: first pass, highlight vital signs, pain out of proportion, syncope, fever, and amount of bleeding. If any are present, ask 'does this patient need to be stabilized, transferred, or sent to surgery now?' before considering any test option.

Mistake 2

Chooses the answer that reflects personal practice habits or anecdotal experience rather than the option the guideline clearly endorses - e.g., 'I always just treat empirically' or 'I always send a panel first.'

Experienced clinicians often practice in settings with different resources or local customs, and the exam is written against national guidelines (ACOG, CDC, USPSTF/ACIP), not a particular clinic's workflow.

What to do instead

For each heavily tested topic, write a one-line 'guideline default' on a flashcard (e.g., AUB evaluation, PID regimen, abnormal Pap follow-up) and answer from that default unless the stem gives a specific reason to deviate.

Mistake 3

Applies screening intervals and start/stop ages from memory without separating tests by age band and risk status - e.g., offering a Pap every year to a 32-year-old, starting mammography at 35 for an average-risk woman, or omitting the age-45 colorectal cancer start.

Screening recommendations have changed multiple times and differ between ACOG, ACS, and USPSTF, so candidates blend versions or default to what they were taught in school.

What to do instead

Build one master table: cervical cancer (start 21; 21–29 cytology q3y; 30–65 cotest q5y or cytology q3y), breast (individualized decision 40–49, biennial 40/50–74), colorectal (45), osteoporosis, and STI screening. Add a 'risk factors' column and rehearse the table weekly.

Mistake 4

Workups abnormal uterine bleeding identically regardless of age or menopausal status - omitting endometrial sampling in a 52-year-old with new bleeding, or ordering an endometrial biopsy as the first step in a 22-year-old with regular but heavy cycles.

AUB is taught as one algorithm, and candidates memorize the 'biopsy' step without attaching it to the age and risk-factor thresholds that trigger it.

What to do instead

Anchor the rule: any postmenopausal bleeding gets evaluated (transvaginal ultrasound and/or endometrial sampling); in premenopausal patients, biopsy is indicated at age ≥45 or younger with risk factors (obesity, PCOS/chronic anovulation, unopposed estrogen, failed medical therapy).

Mistake 5

Selects a combined hormonal contraceptive without screening for contraindications - prescribing COCs to a 38-year-old who smokes, a patient with migraine with aura, a woman with uncontrolled hypertension, or one in the immediate postpartum period.

The method is so familiar that the contraindication checklist gets skipped, and stems often bury the risk factor in the history (social history, headache description) rather than naming it.

What to do instead

Before choosing any combined method, run the same four questions: age plus smoking status, blood pressure, migraine with aura, and VTE/postpartum status. If any is positive, pivot to progestin-only pills, DMPA, implant, or IUD.

Mistake 6

Treats a sexually transmitted infection correctly but fails to select the option that includes partner management and retesting - e.g., treating chlamydia without partner treatment or without a 3-month retest, or ordering only a urogenital NAAT when the stem describes receptive anal or oral exposure.

Candidates focus on drug and dose and consider the visit complete; the CDC's retest-at-3-months and expedited partner therapy elements are treated as afterthoughts rather than part of the correct answer.

What to do instead

For every STI item, check three boxes before answering: correct regimen, partner treatment/EPT, and retest interval. Also match the NAAT specimen site to the reported exposure.

Mistake 7

Orders imaging or starts medication in a reproductive-age patient without first documenting a pregnancy test, or chooses a category-X/teratogenic agent in a patient who could be pregnant.

Under time pressure, the obvious diagnostic or therapeutic answer feels 'more important' than a pregnancy test, and early pregnancy symptoms overlap with GI and urinary complaints.

What to do instead

For any woman of reproductive age with abdominal pain, bleeding, nausea, or a new medication, run the reflex: 'Is she pregnant until proven otherwise?' Eliminate options that are contraindicated in pregnancy first, then choose.

Mistake 8

Attributes postpartum headache, visual change, or elevated blood pressure to sleep deprivation, migraine, or postpartum blues, missing delayed postpartum preeclampsia - which can present up to 6 weeks after delivery and sometimes without proteinuria.

Candidates mentally close the pregnancy chapter at discharge and consider preeclampsia a third-trimester disease; the stem offers plausible benign alternatives that fit the 'new mother' narrative.

What to do instead

In any postpartum patient within 6 weeks of delivery with headache, visual symptoms, RUQ/epigastric pain, or hypertension, treat preeclampsia as the leading diagnosis: check BP, platelets, liver enzymes, and urine protein, and arrange urgent evaluation.

Mistake 9

Prescribes systemic estrogen for vasomotor symptoms to a woman with a uterus without a progestogen, or starts hormone therapy without addressing the contraindication screen (history of breast cancer, VTE, stroke, undiagnosed bleeding, active liver disease).

The symptom relief question dominates attention, and the endometrial-protection rule and the risk stratification get compressed into 'lowest dose, shortest time' without the companion drug.

What to do instead

Use a two-step template: (1) is the uterus present? If yes, estrogen must be paired with a progestogen (or use a combined product/tissue-selective agent); (2) run the absolute contraindication list before dosing. Then choose route and dose.

Mistake 10

Anchors on a reproductive or psychosocial explanation - menopause, stress, perimenopause, ' hormonal' - and skips screening for thyroid disease, depression, anemia, diabetes, or sleep apnea in a woman presenting with fatigue, weight change, palpitations, or low mood.

The exam's domain framing primes candidates to look for a women's-health answer, and the most familiar diagnosis is the one that surfaces first in memory.

What to do instead

For nonspecific constitutional complaints, force a broad differential first: TSH, CBC, ferritin, A1c, PHQ-2/9, and sleep history. Only exclude the common medical causes once they have been explicitly addressed in the stem.

Mistake 11

Answers ethics, consent, and coordination items by personal values or by 'what the parent/partner wants,' ignoring adolescent confidentiality protections, mandatory reporting duties, or the need to refer outside scope - e.g., disclosing STI results to a 16-year-old's parent, or managing a condition beyond NP scope instead of consulting.

These items are read quickly as 'soft' content, and state law variation makes candidates avoid committing to the rule that the exam tests (confidential reproductive/STI care, reporting of suspected abuse, scope-based referral).

What to do instead

Memorize the principles that hold across states: adolescents may generally consent to STI and contraceptive care confidentially; suspected abuse and certain infections require reporting; when a condition exceeds your scope, the correct answer is consultation/referral, not improvisation.